LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI – Trademark Portfolio

Entity Type: 99

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IUUGH. The owner is based in ANHUISHENG FUYANGSHI.

LINQUANXIAN DANQIAOZHENLIYINGCUN

ANHUISHENG FUYANGSHI 236400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IUUGH
IUUGH
Registered 2020

Trademark Classifications

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI have?

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI file in?

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI's most well-known trademarks?

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI's registered trademark portfolio includes well-known marks such as IUUGH. These are among 1 currently registered trademark in the portfolio.

What is LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI's trademark registration success rate?

LINQUANXIANCHENGMENGDIANZISHANGWUYOUXIANGONGSI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.